A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

BACKGROUND: One–fifth of patients with seemingly ‘curable’ pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed ‘unresectable’ by conventional staging criteria (e.g....

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Jordan M., Tang, Laura H., Klimstra, David S., Brennan, Murray F., Brody, Jonathan R., Rocha, Flavio G., Jia, Xiaoyu, Qin, Li-Xuan, D’Angelica, Michael I., DeMatteo, Ronald P., Fong, Yuman, Jarnagin, William R., O’Reilly, Eileen M., Allen, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391218/
https://www.ncbi.nlm.nih.gov/pubmed/22792233
http://dx.doi.org/10.1371/journal.pone.0040157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391218/
https://www.ncbi.nlm.nih.gov/pubmed/22792233
http://dx.doi.org/10.1371/journal.pone.0040157

Ejemplares similares